Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [07/10/2026 12:42 PDT] Forte Biosciences, Inc. (NASDAQ:FBRX), Up By 100% ($21.32) From $21.32 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [07/09/2026 21:21 PDT] Market Maker Surveillance Report. FBRX, Winning Stocks With Lowest Price Friction For Thursday, July 9th 2026
• [07/06/2026 08:27 PDT] FBRX Expected to Trade Down Short Term
• [06/30/2026 07:46 PDT] FBRX Expected to Trade Up After Bullish Patterns Develop
• [05/28/2026 07:23 PDT] FBRX Expected to Trade Up After Bullish Patterns Develop
• [05/27/2026 11:07 PDT] Forte Biosciences, Inc. (NASDAQ:FBRX), Up By 100% ($21.08) From $21.08 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/27/2026 03:26 PDT] FBRX Are Seasonally Ripe To Go Up In the Next Five Weeks
• [05/19/2026 12:04 PDT] Forte Biosciences, Inc. (NASDAQ:FBRX), Down By 100% ($24.07) From $24.07 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [05/19/2026 12:04 PDT] Forte Biosciences, Inc. (NASDAQ:FBRX), Down By 100% ($24.29) From $24.29 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [05/19/2026 03:22 PDT] FBRX Are Seasonally Ripe To Go Up In the Next Five Weeks
• [05/13/2026 06:58 PDT] FBRX Expected to Trade Down Short Term
• [05/11/2026 06:35 PDT] FBRX Expected to Trade Down Short Term